Bill Text: HI SB688 | 2014 | Regular Session | Introduced

---

Bill Title: Controlled Substances; Marijuana

Spectrum: Slight Partisan Bill (Democrat 3-1)

Status: (Introduced - Dead) 2013-12-18 - Carried over to 2014 Regular Session. [SB688 Detail]

Download: Hawaii-2014-SB688-Introduced.html

---

THE SENATE	S.B. NO.	688
TWENTY-SEVENTH LEGISLATURE, 2013
STATE OF HAWAII

A BILL FOR AN ACT

 

 

relating to controlled substances.

 

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

 

     SECTION 1.  The legislature finds that marijuana does not pose the highest degree of danger or probable danger required by the Uniform Controlled Substances Act for designation as a schedule I controlled substance.  While it still poses a high degree of danger or probable danger, its accepted medical uses and its safe usage under medical supervision indicate that marijuana would more appropriately be classified as a schedule II controlled substance.

The purpose of this Act is to reclassify marijuana from as a hallucinogenic substance listed as a schedule I controlled substance to a hallucinogenic substance listed as a schedule II controlled substance.

     SECTION 2.  Section 329-14, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:

     "(d)  Any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

     (1)  Alpha-ethyltryptamine (AET);

     (2)  2,5-dimethoxy-4-ethylamphetamine (DOET);

     (3)  2,5-dimethoxyamphetamine (2,5-DMA);

     (4)  3,4-methylenedioxy amphetamine;

     (5)  3,4-methylenedioxymethamphetamine (MDMA);

     (6)  N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy-MDA);

     (7)  3,4-methylenedioxy-N-ethylamphetamine (MDE);

     (8)  5-methoxy-3,4-methylenedioxy-amphetamine;

     (9)  4-bromo-2,5-dimethoxy-amphetamine (4-bromo-2,5-DMA);

    (10)  4-Bromo-2,5-dimethoxyphenethylamine (Nexus);

    (11)  3,4,5-trimethoxy amphetamine;

    (12)  Bufotenine;

    (13)  4-methoxyamphetamine (PMA);

    (14)  Diethyltryptamine;

    (15)  Dimethyltryptamine;

    (16)  4-methyl-2,5-dimethoxy-amphetamine;

    (17)  Gamma hydroxybutyrate (GHB) (some other names include gamma hydroxybutyric acid; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);

    (18)  Ibogaine;

    (19)  Lysergic acid diethylamide;

   [(20)  Marijuana;

    (21)] (20) Parahexyl;

   [(22)] (21) Mescaline;

   [(23)] (22) Peyote;

   [(24)] (23) N-ethyl-3-piperidyl benzilate;

   [(25)] (24) N-methyl-3-piperidyl benzilate;

   [(26)] (25) Psilocybin;

   [(27)] (26) Psilocyn;

   [(28)] (27) 1-[1-(2-Thienyl) cyclohexyl] Pyrrolidine (TCPy);

   [(29)] (28) Ethylamine analog of phencyclidine (PCE);

   [(30)] (29) Pyrrolidine analog of phencyclidine (PCPy, PHP);

   [(31)] (30) Thiophene analog of phencyclidine (TPCP; TCP);

   [(32)] (31) Gamma-butyrolactone, including butyrolactone; butyrolactone gamma; 4-butyrolactone; 2(3H)-furanone dihydro; dihydro-2(3H)-furanone; tetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide; 4-butanolide; gamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone and 4-hydroxybutanoic acid lactone with Chemical Abstract Service number 96-48-0 when any such substance is intended for human ingestion;

   [(33)] (32) 1,4 butanediol, including butanediol; butane-1,4-diol; 1,4- butylenes glycol; butylene glycol; 1,4-dihydroxybutane; 1,4- tetramethylene glycol; tetramethylene glycol; tetramethylene 1,4- diol with Chemical Abstract Service number 110-63-4 when any such substance is intended for human ingestion;

   [(34)] (33) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts, and salts of isomers;

   [(35)] (34) N-benzylpiperazine (BZP; 1-benzylpiperazine) its optical isomers, salts, and salts of isomers;

   [(36)] (35) 1-(3-trifluoromethylphenyl)piperazine (TFMPP), its optical isomers, salts, and salts of isomers;

   [(37)] (36) Alpha-methyltryptamine (AMT), its isomers, salts, and salts of isomers;

   [(38)] (37) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts, and salts of isomers;

   [(39)] (38) Salvia divinorum;

   [(40)] (39) Salvinorin A;

   [(41)] (40) Divinorin A; and

   [(42)] (41) 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DIPT) (some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT)."

     SECTION 3.  Section 329-16, Hawaii Revised Statutes, is amended by amending subsection (g) to read as follows:

     "(g)  Hallucinogenic substances, unless listed in another schedule, shall include:

     (1)  Nabilone[.]; and

     (2)  Marijuana."

     SECTION 4.  This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.

     SECTION 5.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 6.  This Act shall take effect upon its approval.

 

INTRODUCED BY:	_____________________________

 

 

Report Title:

Controlled Substances; Marijuana

 

Description:

Reclassifies marijuana from a schedule I to a schedule II controlled substance.

 

 

 

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.